Does indomethacin prophylaxis benefit extremely low birth weight infants? Results of a placebo-controlled multicenter trial

Pediatric Research

Volumn 51, Issue 1, 2002, Pages 1-

  Tyson, J E ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; PLACEBO;

BRAIN HEMORRHAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INFANT; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; NOTE; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; VERY LOW BIRTH WEIGHT;

EID: 0036134068     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200201000-00001     Document Type: Note

References (3)

1. Intravenous indomethacin for preventing mortality and morbidity in very low birth weight infants (Cochrane review)
2. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials
3. Outcome of Children in the indomethacin intraventricular hemorrhage prevention trial